Jenessa B. Smith

923 total citations
18 papers, 524 citations indexed

About

Jenessa B. Smith is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Jenessa B. Smith has authored 18 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 8 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Jenessa B. Smith's work include CAR-T cell therapy research (17 papers), Virus-based gene therapy research (5 papers) and Immunotherapy and Immune Responses (5 papers). Jenessa B. Smith is often cited by papers focused on CAR-T cell therapy research (17 papers), Virus-based gene therapy research (5 papers) and Immunotherapy and Immune Responses (5 papers). Jenessa B. Smith collaborates with scholars based in United States, Switzerland and Italy. Jenessa B. Smith's co-authors include Daniel J. Powell, Caitlin Stashwick, Keith Schutsky, Josh Tycko, April R. Giles, James M. Wilson, Laura Bryant, Jesse L. Rodriguez, Christian Hinderer and Elizabeth A. Traxler and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Jenessa B. Smith

18 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jenessa B. Smith United States 10 311 244 191 156 65 18 524
Berith Nilsson Sweden 9 282 0.9× 203 0.8× 199 1.0× 223 1.4× 40 0.6× 12 541
Caleph B. Wilson United States 7 356 1.1× 139 0.6× 110 0.6× 351 2.3× 92 1.4× 8 602
Anna C. Filley United States 7 315 1.0× 133 0.5× 127 0.7× 225 1.4× 59 0.9× 10 547
Simona Porcellini Italy 14 229 0.7× 282 1.2× 153 0.8× 235 1.5× 55 0.8× 25 581
Mahmoud S. Alghamri United States 13 136 0.4× 198 0.8× 70 0.4× 169 1.1× 45 0.7× 24 509
Jessie M. Wu United Kingdom 8 238 0.8× 122 0.5× 77 0.4× 128 0.8× 52 0.8× 13 441
Inti Peredo Sweden 13 213 0.7× 158 0.6× 43 0.2× 247 1.6× 31 0.5× 18 766
Joanna Budna Poland 15 170 0.5× 304 1.2× 99 0.5× 89 0.6× 34 0.5× 60 737
Tapan Ganguly United States 12 132 0.4× 289 1.2× 98 0.5× 57 0.4× 45 0.7× 23 543
Pilvi Maliniemi Finland 10 272 0.9× 248 1.0× 92 0.5× 138 0.9× 62 1.0× 16 505

Countries citing papers authored by Jenessa B. Smith

Since Specialization
Citations

This map shows the geographic impact of Jenessa B. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenessa B. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenessa B. Smith more than expected).

Fields of papers citing papers by Jenessa B. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenessa B. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenessa B. Smith. The network helps show where Jenessa B. Smith may publish in the future.

Co-authorship network of co-authors of Jenessa B. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Jenessa B. Smith. A scholar is included among the top collaborators of Jenessa B. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenessa B. Smith. Jenessa B. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Landon, Mark B., Irene Scarfò, Michelle Nguyen, et al.. (2024). Development of AB-2100, an autologous integrated circuit T (ICT) cell therapy targeting CA9 intended for the treatment of ccRCC.. Journal of Clinical Oncology. 42(4_suppl). 472–472. 1 indexed citations
2.
Chang, Alice Y., Stella Tran, Dina Polyak, et al.. (2022). 277 Development of a robust manufacturing process for AB-1015, an integrated circuit T cell (ICT) product, using targeted, CRISPR integration of transgenes by electroporation (CITE) editing. Regular and Young Investigator Award Abstracts. A292–A292. 4 indexed citations
3.
Smith, Jenessa B., et al.. (2018). Abstract A071: PSMA-specific CARTyrin T-stem cell memory therapy eliminates solid tumor in subcutaneous prostate cancer model. Cancer Research. 78(16_Supplement). A071–A071. 3 indexed citations
4.
Wang, Xinxin, Burton E. Barnett, Christopher E. Martin, et al.. (2017). Production of Universal Anti-Bcma CAR-T Cells with Reduced Alloreactivity, but Potent Effector Function for the Treatment of Multiple Myeloma. Blood. 130. 503–503. 3 indexed citations
5.
Hermanson, David, Burton E. Barnett, Christopher E. Martin, et al.. (2017). Abstract 3759: PiggyBac-manufactured anti-BCMA Centyrin-based CAR-T therapeutic exhibits improved potency and durability. Cancer Research. 77(13_Supplement). 3759–3759. 1 indexed citations
6.
Wang, Xinxin, Xianghong Li, Burton E. Barnett, et al.. (2017). High-fidelity genome editing using NextGEN CRISPR (Clo51-dCas9) system for the production of allogeneic CAR-T cells.. Journal of Clinical Oncology. 35(15_suppl). 3048–3048. 1 indexed citations
7.
Panjwani, M. Kazim, Jenessa B. Smith, Keith Schutsky, et al.. (2016). Feasibility and Safety of RNA-transfected CD20-specific Chimeric Antigen Receptor T Cells in Dogs with Spontaneous B Cell Lymphoma. Molecular Therapy. 24(9). 1602–1614. 90 indexed citations
8.
Barnett, Burton E., David Hermanson, Jenessa B. Smith, et al.. (2016). piggyBacTM-Produced CAR-T Cells Exhibit Stem-Cell Memory Phenotype. Blood. 128(22). 2167–2167. 17 indexed citations
9.
Smith, Jenessa B., Evripidis Lanitis, Denarda Dangaj Laniti, et al.. (2016). Tumor Regression and Delayed Onset Toxicity Following B7-H4 CAR T Cell Therapy. Molecular Therapy. 24(11). 1987–1999. 45 indexed citations
10.
Hermanson, David, Burton E. Barnett, Xinxin Wang, et al.. (2016). A Novel Bcma-Specific, Centyrin-Based CAR-T Product for the Treatment of Multiple Myeloma. Blood. 128(22). 2127–2127. 30 indexed citations
11.
Datta, Jashodeep, Shuwen Xu, Cinthia Rosemblit, et al.. (2015). CD4+ T-Helper Type 1 Cytokines and Trastuzumab Facilitate CD8+ T-cell Targeting of HER2/ neu –Expressing Cancers. Cancer Immunology Research. 3(5). 455–463. 29 indexed citations
12.
Smith, Jenessa B., Evripidis Lanitis, Denarda Dangaj Laniti, et al.. (2015). 514. Targeting the Negative Immune Regulatory Molecule B7-H4 on Both Tumor and Normal Tissue With Anti-B7-H4 CAR T Cells. Molecular Therapy. 23. S206–S206. 1 indexed citations
13.
Schutsky, Keith, Rachel C. Lynn, Jenessa B. Smith, et al.. (2015). Rigorous optimization and validation of potent RNA CAR T cell therapy for the treatment of common epithelial cancers expressing folate receptor. Oncotarget. 6(30). 28911–28928. 39 indexed citations
14.
Smith, Jenessa B., M. Kazim Panjwani, Keith Schutsky, et al.. (2015). Feasibility and safety of cCD20 RNA CAR-bearing T cell therapy for the treatment of canine B cell malignancies. Journal for ImmunoTherapy of Cancer. 3(S2). 6 indexed citations
15.
Smith, Jenessa B., Caitlin Stashwick, & Daniel J. Powell. (2014). B7-H4 as a potential target for immunotherapy for gynecologic cancers: A closer look. Gynecologic Oncology. 134(1). 181–189. 49 indexed citations
16.
Lanitis, Evripidis, Jenessa B. Smith, Denarda Dangaj Laniti, et al.. (2014). A Human ErbB2-Specific T-Cell Receptor Confers Potent Antitumor Effector Functions in Genetically Engineered Primary Cytotoxic Lymphocytes. Human Gene Therapy. 25(8). 730–739. 14 indexed citations
17.
Bryant, Laura, April R. Giles, Christian Hinderer, et al.. (2013). Lessons Learned from the Clinical Development and Market Authorization of Glybera. PubMed. 24(2). 55–64. 145 indexed citations
18.
Orvis, Grant D., Andrea L. Hartzell, Jenessa B. Smith, et al.. (2012). The engrailed homeobox genes are required in multiple cell lineages to coordinate sequential formation of fissures and growth of the cerebellum. Developmental Biology. 367(1). 25–39. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Berith Nilsson Breakdown of academic impact, for papers by Caleph B. Wilson Breakdown of academic impact, for papers by Anna C. Filley Breakdown of academic impact, for papers by Simona Porcellini Breakdown of academic impact, for papers by Mahmoud S. Alghamri Breakdown of academic impact, for papers by Jessie M. Wu Breakdown of academic impact, for papers by Inti Peredo Breakdown of academic impact, for papers by Joanna Budna Breakdown of academic impact, for papers by Tapan Ganguly Breakdown of academic impact, for papers by Pilvi Maliniemi
Rankless by CCL
2026